This compound is a pharmaceutical intermediate featuring a pyrrolo[2,3-d]pyrimidine core substituted with a pyrazole ring and a pivalate ester group. It is primarily used in the synthesis of other active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1146629-77-7
(betaR)-4-Bromo-beta-cyclopentyl-1H-pyrazole-1-propanenitrile
pharmaceutical intermediate
(3R)-3-Cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile
pharmaceutical intermediate
Tert-Butyl (2S,4R)-4-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)pyrrolidine-1-carboxylate
pharmaceutical intermediate
Methyl cis-1-Boc-4-hydroxy-D-prolinate
pharmaceutical intermediate
4-(1H-Pyrazol-4-yl)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine
Research compound
4-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
research compound
[4-(1H-pyrazol-4-yl)pyrrolo[2,3-d]pyrimidin-7-yl]methyl 2,2-dimethylpropanoate
CPGIWDOJHYCMRW-UHFFFAOYSA-N
CC(C)(C)C(=O)OCN1C=CC2=C(N=CN=C21)C3=CNN=C3